Clinical Trial

A Trial of Varenicline for E-cigarette Cessation

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is randomized, placebo-controlled clinical trial in treatment-seeking adults who report regular e-cigarette use to test the hypothesis that varenicline is efficacious for quitting e-cigarettes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-18; most recent amendment 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2025-10-06
Trial Details
NCT Number NCT07040566
Lead Sponsor Yale University
Collaborators: National Cancer Institute (NCI)
Conditions E-cigarette Use, Vaping, Nicotine Dependence
Enrollment 326 participants
Start Date 2025-10-14
Primary Completion 2030-07-30 (estimated)
Study Completion 2030-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-17